Authors

• Gregory Y.H. Lip (ORCID: https://orcid.org/0000-0002-7566-1626)
• Wenhui Li (ORCID: https://orcid.org/0009-0003-0772-2575)
• Ying X. Gue (ORCID: https://orcid.org/0000-0001-9994-8915)
• Eva Soler‐Espejo (ORCID: https://orcid.org/0000-0003-4925-4864)
• Garry McDowell (ORCID: https://orcid.org/0000-0002-2880-5236)
• Manlin Zhao (ORCID: https://orcid.org/0000-0002-5073-1798)
• Douglas L. Packer (ORCID: https://orcid.org/0000-0003-2060-869X)
• Yang Chen (ORCID: https://orcid.org/0000-0002-2808-6286)
• Kui Hong (ORCID: https://orcid.org/0000-0001-9416-0862)

Institutions

• Medical University of Białystok (PL)
• University of Liverpool (GB)
• University of Exeter (GB)
• Intermountain Medical Center (US)
• Liverpool Heart and Chest Hospital (GB)
• National Clinical Research Center for Digestive Diseases (CN)
• First Affiliated Hospital of Jiangxi Medical College (CN)
• Beijing Anzhen Hospital (CN)
• Instituto Murciano de Investigación Biosanitaria (ES)
• Liverpool John Moores University (GB)
• Universidad de Murcia (ES)
• Aalborg University (DK)

Publication Details

Journal

EP Europace

Published

2025-11-07

DOI

https://doi.org/10.1093/europace/euaf292

Primary Topic

Atrial Fibrillation Management and Outcomes

Type

article

Field-Weighted Citation Impact

0.00

Funders

• National Institutes of Health